OpenURL Connection Search

Select item for more details and to access through your institution.

How little is too much? p53 inactivation: from laboratory cutoff to biological basis of chemotherapy resistance.
Published in:
2008
By:
- Zenz, T.;
- Häbe, S.;
- Denzel, T.;
- Winkler, D.;
- Döhner, H.;
- Stilgenbauer, S.
Publication type:
Letter
A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia.
Published in:
2008
By:
- Martelli, M. P.;
- Manes, N.;
- Liso, A.;
- Pettirossi, V.;
- Galletti, B. Verducci;
- Bigerna, B.;
- Pucciarini, A.;
- De Marco, M. F.;
- Pallotta, M. T.;
- Bolli, N.;
- Sborgia, M.;
- di Raimondo, F.;
- Fabbiano, F.;
- Meloni, G.;
- Specchia, G.;
- Martelli, M. F.;
- Falini, B.
Publication type:
Letter
Claimed association of absolute lymphocyte count with therapeutic efficacy of radio-immunotherapy in patients with indolent lymphoma cannot be verified in an independent data set.
Published in:
2008
By:
- Bishton, M. J.;
- Hicks, R. J.;
- Prince, H. M.;
- Ritchie, D. S.;
- Wolf, M.;
- Seymour, J. F.
Publication type:
Letter
Oncolytic virotherapy for multiple myeloma using a tumour-specific double-deleted vaccinia virus.
Published in:
2008
By:
- Deng, H.;
- Tang, N.;
- Stief, A. E.;
- Mehta, N.;
- Baig, E.;
- Head, R.;
- Sleep, G.;
- Yang, X.-Z.;
- McKerlie, C.;
- Trudel, S.;
- Stewart, A. K.;
- McCart, J. A.
Publication type:
Letter
Improving minimal residual disease detection in precursor B-ALL based on immunoglobulin-κ and heavy-chain gene rearrangements.
Published in:
2008
By:
- Sutton, R.;
- Bahar, A. Y.;
- Kwan, E.;
- Giles, J. E.;
- Venn, N. C.;
- Tran, S.;
- Hackenberg, N.;
- Pozza, L. Dalla;
- Marshall, G. M.;
- Haber, M.;
- van der Velden, V. H. J.;
- Norris, M. D.
Publication type:
Letter
PKR is activated in MDS patients and its subcellular localization depends on disease severity.
Published in:
2008
By:
- Follo, M. Y.;
- Finelli, C.;
- Mongiorgi, S.;
- Clissa, C.;
- Bosi, C.;
- Martinelli, G.;
- Blalock, W. L.;
- Cocco, L.;
- Martelli, A. M.
Publication type:
Letter
An activating KRAS mutation in imatinib-resistant chronic myeloid leukemia.
Published in:
2008
By:
- Agarwal, A.;
- Eide, C. A.;
- Harlow, A.;
- Corbin, A. S.;
- Mauro, M. J.;
- Druker, B. J.;
- Corless, C. L.;
- Heinrich, M. C.;
- Deininger, M. W.
Publication type:
Case Study
Reply to ‘Claimed association of absolute lymphocyte count with therapeutic efficacy of radio-immunotherapy in patients with indolent lymphoma cannot be verified in an independence data set’ by Mark J Bishton et al.
Published in:
2008
By:
- Porrata, L. F.;
- Ristow, K.;
- Witzig, T. E.;
- Tuinistra, N.;
- Habermann, T. M.;
- Inwards, D. J.;
- Ansell, S. M.;
- Micallef, I. N.;
- Johnston, P. B.;
- Markovic, S. N.
Publication type:
Letter
Cotransplantation of mesenchymal cells and a higher relapse rate: a role for HLA-G molecules?
Published in:
2008
By:
- Rizzo, R.;
- Campioni, D.;
- Lanza, F.;
- Baricordi, O. R.
Publication type:
Letter
Spurious elevation of the cerebrospinous fluid white cell counts in three patients receiving liposomal cytarabine as part of post-remission therapy.
Published in:
2008
By:
- Swords, R.;
- O'Rafferty, C.;
- Giles, F.;
- Browne, P.
Publication type:
Letter
Novel gain-of-function mutation in the extracellular domain of the PDGFRA gene in infant acute lymphoblastic leukemia with t(4;11)(q21;q23).
Published in:
2008
By:
- Hiwatari, M.;
- Ono, R.;
- Taki, T.;
- Hishiya, A.;
- Ishii, E.;
- Kitamura, T.;
- Hayashi, Y.;
- Nosaka, T.
Publication type:
Letter
Clinical and biological significance of RAS mutations in multiple myeloma.
Published in:
2008
By:
- Chng, W. J.;
- Gonzalez-Paz, N.;
- Price-Troska, T.;
- Jacobus, S.;
- Rajkumar, S. V.;
- Oken, M. M.;
- Kyle, R. A.;
- Henderson, K. J.;
- Van Wier, S.;
- Greipp, P.;
- Van Ness, B.;
- Fonseca, R.
Publication type:
Letter
Large interindividual differences in cellular sensitivity to calicheamicin may influence gemtuzumab ozogamicin response in acute myeloid leukemia.
Published in:
2008
By:
- Goemans, B. F.;
- Zwaan, C. M.;
- Vijverberg, S. J. H.;
- Loonen, A. H.;
- Creutzig, U.;
- Hählen, K.;
- Reinhardt, D.;
- Gibson, B. E. S.;
- Cloos, J.;
- Kaspers, G. J. L.;
- Hählen, K
Publication type:
Letter
Notch inhibition blocks multiple myeloma cell-induced osteoclast activation.
Published in:
2008
By:
- Schwarzer, R.;
- Kaiser, M.;
- Acikgoez, O.;
- Heider, U.;
- Mathas, S.;
- Preissner, R.;
- Sezer, O.;
- Doerken, B.;
- Jundt, F.
Publication type:
Letter
Highly sensitive and quantitative detection of BCR-ABL kinase domain mutations by ligation PCR.
Published in:
2008
By:
- Pelz-Ackermann, O.;
- Cross, M.;
- Pfeifer, H.;
- Deininger, M.;
- Wang, S.-Y.;
- Al-Ali, H. K.;
- Niederwieser, D.;
- Lange, T.
Publication type:
Letter
SOCS2: inhibitor of JAK2V617F-mediated signal transduction.
Published in:
Leukemia (08876924), 2008, v. 22, n. 12, p. 2169, doi. 10.1038/leu.2008.226
By:
- Quentmeier, H.;
- Geffers, R.;
- Jost, E.;
- MacLeod, R. A. F.;
- Nagel, S.;
- Röhrs, S.;
- Romani, J.;
- Scherr, M.;
- Zaborski, M.;
- Drexler, H. G.
Publication type:
Article
Etiology of common childhood acute lymphoblastic leukemia: the adrenal hypothesis.
Published in:
Leukemia (08876924), 2008, v. 22, n. 12, p. 2137, doi. 10.1038/leu.2008.212
By:
- Schmiegelow, K.;
- Vestergaard, T.;
- Nielsen, S. M.;
- Hjalgrim, H.
Publication type:
Article
Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase.
Published in:
2008
By:
- Cortes, J.;
- Kim, D.-W.;
- Raffoux, E.;
- Martinelli, G.;
- Ritchie, E.;
- Roy, L.;
- Coutre, S.;
- Corm, S.;
- Hamerschlak, N.;
- Tang, J.-L.;
- Hochhaus, A.;
- Khoury, H. J.;
- Brümmendorf, T. H.;
- Michallet, M.;
- Rege-Cambrin, G.;
- Gambacorti-Passerini, C.;
- Radich, J. P.;
- Ernst, T.;
- Zhu, C.;
- Van Tornout, J. M. A.
Publication type:
journal article
Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndrome.
Published in:
2008
By:
- Krejsgaard, T.;
- Gjerdrum, L. M.;
- Ralfkiaer, E.;
- Lauenborg, B.;
- Eriksen, K. W.;
- Mathiesen, A.-M.;
- Bovin, L. F.;
- Gniadecki, R.;
- Geisler, C.;
- Ryder, L. P.;
- Zhang, Q.;
- Wasik, M. A.;
- Ødum, N.;
- Woetmann, A.;
- Odum, N
Publication type:
journal article
Minimal residual disease is an important predictive factor of outcome in children with relapsed ‘high-risk’ acute lymphoblastic leukemia.
Published in:
Leukemia (08876924), 2008, v. 22, n. 12, p. 2193, doi. 10.1038/leu.2008.227
By:
- Paganin, M.;
- Zecca, M.;
- Fabbri, G.;
- Polato, K.;
- Biondi, A.;
- Rizzari, C.;
- Locatelli, F.;
- Basso, G.
Publication type:
Article
Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
Published in:
Leukemia (08876924), 2008, v. 22, n. 12, p. 2226, doi. 10.1038/leu.2008.230
By:
- Klapper, W.;
- Stoecklein, H.;
- Zeynalova, S.;
- Ott, G.;
- Kosari, F.;
- Rosenwald, A.;
- Loeffler, M.;
- Trümper, L.;
- Pfreundschuh, M.;
- Siebert, Reiner
Publication type:
Article
Regulation of IL-2 expression by transcription factor BACH2 in umbilical cord blood CD4<sup>+</sup> T cells.
Published in:
Leukemia (08876924), 2008, v. 22, n. 12, p. 2201, doi. 10.1038/leu.2008.234
By:
- Lesniewski, M. L.;
- Haviernik, P.;
- Weitzel, R. P.;
- Kadereit, S.;
- Kozik, M. M.;
- Fanning, L. R.;
- Yang, Y. C.;
- Hegerfeldt, Y.;
- Finney, M. R.;
- Ratajczak, M. Z.;
- Greco, N.;
- Paul, P.;
- Maciejewski, J.;
- Laughlin, M. J.
Publication type:
Article
Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study.
Published in:
2008
By:
- Nguyen, K.;
- Devidas, M.;
- Cheng, S.-C.;
- La, M.;
- Raetz, E. A.;
- Carroll, W. L.;
- Winick, N. J.;
- Hunger, S. P.;
- Gaynon, P. S.;
- Loh, M. L.;
- Children's Oncology Group
Publication type:
journal article
The combination of bortezomib, melphalan, dexamethasone and intermittent thalidomide is an effective regimen for relapsed/refractory myeloma and is associated with improvement of abnormal bone metabolism and angiogenesis.
Published in:
2008
By:
- Terpos, E;
- Kastritis, E;
- Roussou, M;
- Heath, D;
- Christoulas, D;
- Anagnostopoulos, N;
- Eleftherakis-Papaiakovou, E;
- Tsionos, K;
- Croucher, P;
- Dimopoulos, M A
Publication type:
Correction Notice
The combination of bortezomib, melphalan, dexamethasone and intermittent thalidomide is an effective regimen for relapsed/refractory myeloma and is associated with improvement of abnormal bone metabolism and angiogenesis.
Published in:
Leukemia (08876924), 2008, v. 22, n. 12, p. 2247, doi. 10.1038/leu.2008.235
By:
- Terpos, E.;
- Kastritis, E.;
- Roussou, M.;
- Heath, D.;
- Christoulas, D.;
- Anagnostopoulos, N.;
- Eleftherakis-Papaiakovou, E.;
- Tsionos, K.;
- Croucher, P.;
- Dimopoulos, M. A.
Publication type:
Article
Regulation of IL-2 expression by transcription factor BACH2 in umbilical cord blood CD4<sup>+</sup>T cells.
Published in:
2008
By:
- Lesniewski, M L;
- Haviernik, P;
- Weitzel, R P;
- Kadereit, S;
- Kozik, M M;
- Fanning, L R;
- Yang, Y C;
- Hegerfeldt, Y;
- Finney, M R;
- Ratajczak, M Z;
- Greco, N;
- Paul, P;
- Maciejewski, J;
- Laughlin, M J
Publication type:
Correction Notice
The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation.
Published in:
2008
By:
- Tavor, S.;
- Eisenbach, M.;
- Jacob-Hirsch, J.;
- Golan, T.;
- Petit, I.;
- BenZion, K.;
- Kay, S.;
- Baron, S.;
- Amariglio, N.;
- Deutsch, V.;
- Naparstek, E.;
- Rechavi, G.
Publication type:
journal article
Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia.
Published in:
Leukemia (08876924), 2008, v. 22, n. 12, p. 2184, doi. 10.1038/leu.2008.241
By:
- Weinberg, J. B.;
- Volkheimer, A. D.;
- Mihovilovic, M.;
- Jiang, N.;
- Chen, Y.;
- Bond, K.;
- Moore, J. O.;
- Gockerman, J. P.;
- Diehl, L. F.;
- de Castro, C. M.;
- Rizzieri, D. A.;
- Levesque, M. C.;
- DeKroon, R.;
- Strittmatter, W. J.
Publication type:
Article
Intrinsic differences between the catalytic properties of the oncogenic NUP214-ABL1 and BCR-ABL1 fusion protein kinases.
Published in:
Leukemia (08876924), 2008, v. 22, n. 12, p. 2208, doi. 10.1038/leu.2008.242
By:
- De Keersmaecker, K.;
- Versele, M.;
- Cools, J.;
- Superti-Furga, G.;
- Hantschel, O.
Publication type:
Article
Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cells.
Published in:
Leukemia (08876924), 2008, v. 22, n. 12, p. 2159, doi. 10.1038/leu.2008.243
By:
- Nishioka, C.;
- Ikezoe, T.;
- Yang, J.;
- Koeffler, H. P.;
- Yokoyama, A.
Publication type:
Article
ICER expression inhibits leukemia phenotype and controls tumor progression.
Published in:
Leukemia (08876924), 2008, v. 22, n. 12, p. 2217, doi. 10.1038/leu.2008.244
By:
- Pigazzi, M.;
- Manara, E.;
- Baron, E.;
- Basso, G.
Publication type:
Article
A role for IFN-lambda1 in multiple myeloma B cell growth.
Published in:
2008
By:
- Novak, A. J.;
- Grote, D. M.;
- Ziesmer, S. C.;
- Rajkumar, V.;
- Doyle, S. E.;
- Ansell, S. M.
Publication type:
journal article

Found: 32